Tuesday, October 27, 2015
Global CRO Quintiles and IMS Health, a global information and technology services company, have announced a global strategic alliance that will advance the way biopharmaceutical companies generate real-world evidence (RWE) and apply critical insights to drive late-stage clinical research. Offering complementary strengths in real-world data management, operational delivery, advanced analytics and scientific and therapeutic expertise, the collaboration is designed to accelerate assessments of treatment impact and help improve patient outcomes.
CluePoints, a software provider of risk-based monitoring (RBM) solutions for clinical trials, has partnered with eClinical solutions provider OmniComm Systems. The two companies will work together to deliver OmniComm’s electronic data capture (EDC) technology and services integrated with CluePoints’ RBM software, offering customers a best-in-class solution that couples data collection with complete oversight of data quality.
ERT, a Philadelphia-based cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions, has announced that several prototypes from its Innovation Lab now are available for public demonstrations. The Boston-based Innovation Lab continuously explores pervasive telemetry for clinical research and broad clinical care.
Johns Hopkins researchers have introduced EpiWatch, designed to use the Apple Watch to collect patient data through the open source ResearchKit framework designed by Apple. The app, which runs on the Apple Watch and iPhone, collects data from patients with epilepsy before, during and after their seizures.
Simulations Plus, a Lancaster, Calif.-based provider of simulation and modeling software for pharmaceutical discovery and development, is expanding its offerings of best-in-class software for pharmaceutical R&D with PKPlus, a new program that provides user-friendly analysis and reporting of clinical trial data for use in submissions to regulatory agencies.
CluePoints, a Cambridge, Mass.-based software provider of risk-based monitoring (RBM) solutions for clinical trials, has partnered with Bracket Global, a provider of technologies and services that drive superior clinical outcome results. The exclusive partnership will see CluePoints’ RBM software offered in combination with Bracket’s Blinded Data Analytics and Rater Training and Quality Assurance oversight program for psychiatry and neurology trials. Bringing together CluePoints’ and Bracket’s solutions will enhance the impact of the services that each company delivers to sponsors, improving the integrity and quality of clinical data.
The Centers for Disease Control and Prevention, through the National Center for Emerging and Zoonotic Infectious Diseases, Office of Advanced Molecular Detection (OAMD), and Edico Genome have entered into a research collaboration to evaluate the performance of Edico Genome’s DRAGEN hardware platform. The goal of this research collaboration is to evaluate the utility of the Edico Genome DRAGEN platform for public health and infectious disease applications. This collaboration also will focus on co-developing the databases, configurations and parameters to optimize the hardware platform for microbial applications.